Showing results (521-530 of 559) with videos related to
Sort By:
Pageof 56
Sleep|March 7, 2023
Pediatric sleep: current knowledge, gaps, and opportunities for the futureAlexandria M Reynolds, Andrea M Spaeth, Lauren Hale, et al.JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.Nucleic Acids Research|April 29, 2015
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerJeremy Chien, Hugues Sicotte, Jian-Bing Fan, et al.Breast Cancer Research and Treatment|August 23, 2015
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapyMarissa S Ellingson, Steven N Hart, Krishna R Kalari, et al.Journal of the National Cancer Institute|May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJulie R Palmer, Eric C Polley, Chunling Hu, et al.NPJ Breast Cancer|July 13, 2024
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancerPeter A Fasching, Chunling Hu, Steven N Hart, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisoneL Wang, S M Dehm, D W Hillman, et al.Cancer Research|October 25, 2013
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinomaBrandon Leonard, Steven N Hart, Michael B Burns, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on PrognosisPeter A Fasching, Siddhartha Yadav, Chunling Hu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in <i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>Siddhartha Yadav, Nicholas J Boddicker, Jie Na, et al.Pageof 56